Suchergebnisse - "Tabernero, J"

PubPharm (65)

1

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology | 31 July 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +12

2

Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del Paggio

enthalten in: Annals of oncology | 2017

von Cherny, N. | Dafni, U. | Bogaerts, J. | +5

3

ESMO-Magnitude of Clinical Benefit Scale version 1.1

enthalten in: Annals of oncology | 2017

von Cherny, N. | Dafni, U. | Bogaerts, J. | +7

4

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weeklynab-paclitaxel plus gemcitabine vs gemcitabine alone in patients with metastatic pancreatic cancer

enthalten in: Annals of oncology | 2016

von Chiorean, E. | Von Hoff, D. | Reni, M. | +14

5

Positron Emission Tomography Response Evaluation from a Randomized Phase III Trial of Weeklynab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Patients With Metastatic Adenocarcinoma of the Pancreas

enthalten in: Annals of oncology | 2016

von Ramanathan, R. | Goldstein, D. | Korn, R. | +10

6

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

enthalten in: Annals of oncology | 2016

von Chiorean, E. | Von Hoff, D. | Reni, M. | +14

7

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas

enthalten in: Annals of oncology | 2016

von Ramanathan, R. | Goldstein, D. | Korn, R. | +10

8

PD-029Baseline carcinoembryonic antigen (CEA) as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma (mCRC) phase 3 trial

enthalten in: Annals of oncology | 2016

von Yoshino, T. | Obermannová, R. | Bodoky, G. | +9

9

PD-025RECOURSE trial: impact of adverse events on quality of life and duration of TAS-102 (trifluridine and tipiracil) treatment

enthalten in: Annals of oncology | 2016

von Tabernero, J. | Mayer Robert, J. | Ohtsu, A. | +16

10

PD-024Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

enthalten in: Annals of oncology | 2016

von Siena, S. | Tabernero, J. | Bodoky, G. | +7

1
2
3
4
5
6
7
Nächster »
[7]